Screening for open angle glaucoma

Systematic Review of Cost-effectiveness Studies

Rodolfo Andrés Hernández, Kannaiyan Rabindranath, Cynthia Mary Fraser, Luke David Vale, Augusto Azuara-Blanco, Jennifer Margaret Burr, OAG Screening Project Grp

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: To systematically review current evidence on the cost-effectiveness of screening strategies for open angle glaucoma (OAG).

Materials and Methods: Studies that reported both costs and outcomes of alternative screening strategies for OAG were identified by a highly sensitive search of electronic databases (eg, MEDLINE, EMBASE, NHS EED, HTA Database), last search December 2005. Data on costs regarding cases and years of visual impairment prevented, cases of blindness prevented, and cases of OAG detected were extracted. Incremental cost-effectiveness ratios were calculated using data provided in the included studies.

Results: Four studies met the inclusion criteria. The latest of these was published in 1997. The screening tests and treatments reported in these studies are now not considered to be best practice. Furthermore, data were not reported in sufficient detail to reinterpret the results of the studies in terms of a common outcome measure. Finally, these studies suffered from methodologic weaknesses that further limit their usefulness for decision making.

Conclusions: Currently, there is insufficient economic evidence on which to base recommendations regarding screening for OAG. New technologies, potentially suitable as screening devices, and new treatments are available. Further research, both in terms of economic models and conduct of clinical trials with concurrent economic evaluation, may help inform policy makers regarding cost-effectiveness and acceptability of screening for OAG.

Original languageEnglish
Pages (from-to)159-168
Number of pages10
JournalJournal of Glaucoma
Volume17
Issue number3
DOIs
Publication statusPublished - Apr 2008

Keywords

  • economic evaluation
  • cost-effectiveness
  • systematic review
  • screening
  • glaucoma

Cite this

Hernández, R. A., Rabindranath, K., Fraser, C. M., Vale, L. D., Azuara-Blanco, A., Burr, J. M., & OAG Screening Project Grp (2008). Screening for open angle glaucoma: Systematic Review of Cost-effectiveness Studies. Journal of Glaucoma, 17(3), 159-168. https://doi.org/10.1097/IJG.0b013e31814b9693

Screening for open angle glaucoma : Systematic Review of Cost-effectiveness Studies. / Hernández, Rodolfo Andrés; Rabindranath, Kannaiyan; Fraser, Cynthia Mary; Vale, Luke David; Azuara-Blanco, Augusto; Burr, Jennifer Margaret; OAG Screening Project Grp.

In: Journal of Glaucoma, Vol. 17, No. 3, 04.2008, p. 159-168.

Research output: Contribution to journalArticle

Hernández, RA, Rabindranath, K, Fraser, CM, Vale, LD, Azuara-Blanco, A, Burr, JM & OAG Screening Project Grp 2008, 'Screening for open angle glaucoma: Systematic Review of Cost-effectiveness Studies', Journal of Glaucoma, vol. 17, no. 3, pp. 159-168. https://doi.org/10.1097/IJG.0b013e31814b9693
Hernández, Rodolfo Andrés ; Rabindranath, Kannaiyan ; Fraser, Cynthia Mary ; Vale, Luke David ; Azuara-Blanco, Augusto ; Burr, Jennifer Margaret ; OAG Screening Project Grp. / Screening for open angle glaucoma : Systematic Review of Cost-effectiveness Studies. In: Journal of Glaucoma. 2008 ; Vol. 17, No. 3. pp. 159-168.
@article{7d79ad71ece3472891f1be80ea398263,
title = "Screening for open angle glaucoma: Systematic Review of Cost-effectiveness Studies",
abstract = "Purpose: To systematically review current evidence on the cost-effectiveness of screening strategies for open angle glaucoma (OAG).Materials and Methods: Studies that reported both costs and outcomes of alternative screening strategies for OAG were identified by a highly sensitive search of electronic databases (eg, MEDLINE, EMBASE, NHS EED, HTA Database), last search December 2005. Data on costs regarding cases and years of visual impairment prevented, cases of blindness prevented, and cases of OAG detected were extracted. Incremental cost-effectiveness ratios were calculated using data provided in the included studies.Results: Four studies met the inclusion criteria. The latest of these was published in 1997. The screening tests and treatments reported in these studies are now not considered to be best practice. Furthermore, data were not reported in sufficient detail to reinterpret the results of the studies in terms of a common outcome measure. Finally, these studies suffered from methodologic weaknesses that further limit their usefulness for decision making.Conclusions: Currently, there is insufficient economic evidence on which to base recommendations regarding screening for OAG. New technologies, potentially suitable as screening devices, and new treatments are available. Further research, both in terms of economic models and conduct of clinical trials with concurrent economic evaluation, may help inform policy makers regarding cost-effectiveness and acceptability of screening for OAG.",
keywords = "economic evaluation, cost-effectiveness, systematic review, screening, glaucoma",
author = "Hern{\'a}ndez, {Rodolfo Andr{\'e}s} and Kannaiyan Rabindranath and Fraser, {Cynthia Mary} and Vale, {Luke David} and Augusto Azuara-Blanco and Burr, {Jennifer Margaret} and {OAG Screening Project Grp}",
year = "2008",
month = "4",
doi = "10.1097/IJG.0b013e31814b9693",
language = "English",
volume = "17",
pages = "159--168",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Screening for open angle glaucoma

T2 - Systematic Review of Cost-effectiveness Studies

AU - Hernández, Rodolfo Andrés

AU - Rabindranath, Kannaiyan

AU - Fraser, Cynthia Mary

AU - Vale, Luke David

AU - Azuara-Blanco, Augusto

AU - Burr, Jennifer Margaret

AU - OAG Screening Project Grp

PY - 2008/4

Y1 - 2008/4

N2 - Purpose: To systematically review current evidence on the cost-effectiveness of screening strategies for open angle glaucoma (OAG).Materials and Methods: Studies that reported both costs and outcomes of alternative screening strategies for OAG were identified by a highly sensitive search of electronic databases (eg, MEDLINE, EMBASE, NHS EED, HTA Database), last search December 2005. Data on costs regarding cases and years of visual impairment prevented, cases of blindness prevented, and cases of OAG detected were extracted. Incremental cost-effectiveness ratios were calculated using data provided in the included studies.Results: Four studies met the inclusion criteria. The latest of these was published in 1997. The screening tests and treatments reported in these studies are now not considered to be best practice. Furthermore, data were not reported in sufficient detail to reinterpret the results of the studies in terms of a common outcome measure. Finally, these studies suffered from methodologic weaknesses that further limit their usefulness for decision making.Conclusions: Currently, there is insufficient economic evidence on which to base recommendations regarding screening for OAG. New technologies, potentially suitable as screening devices, and new treatments are available. Further research, both in terms of economic models and conduct of clinical trials with concurrent economic evaluation, may help inform policy makers regarding cost-effectiveness and acceptability of screening for OAG.

AB - Purpose: To systematically review current evidence on the cost-effectiveness of screening strategies for open angle glaucoma (OAG).Materials and Methods: Studies that reported both costs and outcomes of alternative screening strategies for OAG were identified by a highly sensitive search of electronic databases (eg, MEDLINE, EMBASE, NHS EED, HTA Database), last search December 2005. Data on costs regarding cases and years of visual impairment prevented, cases of blindness prevented, and cases of OAG detected were extracted. Incremental cost-effectiveness ratios were calculated using data provided in the included studies.Results: Four studies met the inclusion criteria. The latest of these was published in 1997. The screening tests and treatments reported in these studies are now not considered to be best practice. Furthermore, data were not reported in sufficient detail to reinterpret the results of the studies in terms of a common outcome measure. Finally, these studies suffered from methodologic weaknesses that further limit their usefulness for decision making.Conclusions: Currently, there is insufficient economic evidence on which to base recommendations regarding screening for OAG. New technologies, potentially suitable as screening devices, and new treatments are available. Further research, both in terms of economic models and conduct of clinical trials with concurrent economic evaluation, may help inform policy makers regarding cost-effectiveness and acceptability of screening for OAG.

KW - economic evaluation

KW - cost-effectiveness

KW - systematic review

KW - screening

KW - glaucoma

U2 - 10.1097/IJG.0b013e31814b9693

DO - 10.1097/IJG.0b013e31814b9693

M3 - Article

VL - 17

SP - 159

EP - 168

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 3

ER -